Opko Health, Inc.

Description

OPKO Lab is dedicated to providing Urologists and patients with accurate diagnoses within 24 hours for most tests. All clients have access to board certified, urologic fellowship trained OPKO Lab senior pathologists for consultation. OPKO Lab began in 1996 as a urologic reference laboratory providing anatomic, clinical and molecular pathology services. It was with the goal of improving these services that we developed the 4Kscore ™ Test.

Senesco (Bridgewater, NJ) acquired Fabrus (San Diego, CA) in May 2014 and is a publicly traded clinical-stage biotech company specializing in cancer therapeutics. Its proprietary gene regulation technology has demonstrated the ability to kill cancer cells and protect healthy cells from premature death in disease models.

Pharmsynthez (St. Petersberg, Russia), a publicly traded pharmaceutical company that manufactures and markets medicines used in oncology, gynecology, viral diseases and tuberculosis, and conducts clinical development of therapeutic vaccines and bio superiors.

ARNO Therapeutics (Flemington, NJ), a publicly traded biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. ARNO has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors.

Fact sheet

Company contacts

Products & services

Similar companies nearby